본문 바로가기
bar_progress

Text Size

Close

'Phase 3 Clinical Safety Confirmed' KPM Tech-Telcon RF Pharma Investment Approved for US Nasdaq Listing!

Those who applied for < KPM Tech (042040) > hit the upper limit in just 5 days! Achieved 200% profit!

Congratulations to everyone who applied for the free trial. ^^


※ For those who missed the “COVID-19 treatment drug,” it’s okay. We are launching again in a big way.

※ Finally starting. KPM Tech (042040) follow-up stock hits the upper limit on Wednesday. ※


▶▶ On September 23, the COVID-19 new drug starting with a huge ‘upper limit’! ‘Lenzilumab’ listed on the US NASDAQ! ‘ㅇㅇㅇㅇㅇㅇㅇ’ related stock! ▶ Apply for free trial ◀


According to Business Wire in the US, the US Data and Safety Monitoring Board (DSMB) unanimously expressed satisfaction with the interim results of the phase 3 clinical trial of Humanigen’s COVID-19 treatment candidate ‘Lenzilumab’.


Lenzilumab, developed by Humanigen, is expected to suppress and prevent the excessive immune response ‘cytokine storm’ that occurs in COVID-19 patients. It is conducting phase 3 clinical trials after receiving approval from the US Food and Drug Administration (FDA).

▶▶ Heading straight ‘up’ on Wednesday. Moving fast. You know it, right? Every time “Remdesivir, Dexamethasone” came out, it exploded! [‘US COVID-19 new drug company invested by domestic companies’ stock apply now]


“I applied and bought small amounts every day for 3 days, and I was really surprised that the upper limit profit came out every day. It’s amazing how this is possible. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Really thankful again and again. Ah! I am actively recommending it to my acquaintances as well.”

(VIP office worker member Yoo Jin Lee, 41 years old)


Now think this is the last chance. If you miss this opportunity, you have to give up.

Exactly on “September 23” it will explode! Don’t miss it and regret it, just buy at least 100,000 KRW worth!



▶▶ “September 23 upper limit” offered only until today and then closed. [‘Lenzilumab’ related stocks you must see from now!] ▶ Receive stocks ◀


[AI recent upper limit hits]

*20.09.16 Daesung Fintech (104040) upper limit hit!

*20.09.15 Jeju Semiconductor (080220) upper limit hit!

*20.09.14 Hyundai Industry (170030) upper limit hit!

*20.09.11 Borak (002760) upper limit hit!

*20.09.10 Dong-A Hwasung (041930) upper limit hit!

*20.09.09 SDN (099220) upper limit hit!

*20.09.08 Chorokbaem (047820) upper limit hit!

*20.09.07 Philosis Healthcare (057880) upper limit hit!

*20.09.04 Unison (018000) upper limit hit!

*20.09.03 Jinyang Pharmaceutical (007370) upper limit hit!

*20.09.02 Youngjin Pharmaceutical (003520) upper limit hit!

*20.09.01 Kolon Material (144620) upper limit hit!

*20.08.31 Sajo Oyang (006090) upper limit hit!

*20.08.28 Parkers (065690) upper limit hit!

*20.08.27 Boditech Med (206640) upper limit hit!

*20.08.26 Telcon RF Pharmaceutical (200230) upper limit hit!

*20.08.25 Woori Bio (082850) upper limit hit!

*20.08.24 Jinwon Life Science (011000) upper limit hit!

*20.08.21 Exaenc (054940) upper limit hit!

*20.08.20 Wooridul Pharmaceutical (004720) 3 consecutive upper limit hits!

*20.08.19 Wooridul Pharmaceutical (004720) 2 consecutive upper limit hits!

*20.08.18 Wooridul Pharmaceutical (004720) upper limit hit!


▶▶ Only 30 people will be given. “Wednesday upper limit”! ▶ Receive now ◀


※ First-come, first-served 30 people closed! Both early and late rounds are over. The hero of the last injury time winning goal ※


[Today’s stocks of interest]

#Jinwon Life Science #KPM Tech #Telcon RF Pharmaceutical #Nara M&D #EnerTalk


※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top